In 2002, Applera assumed that the data held by its Celera Genomics group would produce cash flows of $200 million to $300 million over 10 years and established a royalty plan that would allow its Applied Biosystems group to exclusively market the data until 2012.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.